Testing effectiveness (Phase 2)Ended earlyNCT05275673
What this trial is testing
Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer
Who this might be right for
Non-Small Cell Lung CancerSquamous Non-small-cell Lung CancerSquamous Non-Small Cell Neoplasm of Lung+1 more
Faeth Therapeutics 7